|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-2304-2013 - Advanta VXT Vascular Grafts >or= 6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2305-2013 - Flixene IFG Vascular Grafts >or= 6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2306-2013 - Advanta SuperSoft Grafts >or= 6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2307-2013 - Flixene IFG with Assisted Delivery
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2308-2013 - Advanta SST Bifurcated Grafts >or= 6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2309-2013 - Advanta VS Grafts <6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2317-2013 - Advanta SST Grafts <6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2311-2013 - Advanta SST Grafts >or= 6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2312-2013 - Advanta SuperSoft Grafts <6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|
Z-2313-2013 - Advanta VXT Grafts <6mm
Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
|
2
|
09/30/2013
|
Atrium Medical Corporation
|